Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan-Based Regimens for Eradication of Helicobacter pylori
ChiCTR2400084473Phase 4Recruiting
- Sponsor
- Shandong Second ProvinciaI GeneraI HospitaI
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (3 arms), sponsored by Shandong Second ProvinciaI GeneraI HospitaI. Primary endpoint: Eradication rate of Helicobacter pylori infection. Started May 2024; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400084473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084473.